Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

3SBio Signs Official Go-Private Agreement

publication date: Feb 8, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
3SBio Inc. of Shenyang has agreed to be bought by Dr. Jing Lou, who is the company’s Chairman and CEO, and a CITIC Private Equity company. They will pay non-affiliated shareholders $15.40 per ADS, which values the company at $339 million. The offer was originally made in September of last year at the slightly lower price of $15 per ADS. The transaction is expected to close in Q2 of 2013. More details....

Stock Symbol: (NSDQ: SSRX)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
ChinaBio® Events
Shanghai, China
April 14-15, 2015

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors